---

An open multicenter phase II trial of docetaxel-gemcitabine in Charlson-score and performans status (PS) selected elderly patients with stage IIIB pleural/IV non-small-cell lung cancer (NSCLC) : the GFPC 02-02a study

Critical Reviews in Oncology/Hematology 2007;64:73-81

[pdf]Le Caer et al. Crit Rev Oncol-Hematol 2007_73-81[/pdf]